965 related articles for article (PubMed ID: 11002221)
21. Role of CD80 (B7.1) and CD86 (B7.2) in the immune response to an intracellular pathogen.
Subauste CS; de Waal Malefyt R; Fuh F
J Immunol; 1998 Feb; 160(4):1831-40. PubMed ID: 9469444
[TBL] [Abstract][Full Text] [Related]
22. Autogeneic rna-electroporated CD40-ligand activated b-cells from hepatocellular carcinoma patients induce CD8+ T-cell responses ex vivo.
Shen S; Xu Z; Qian X; Ding Y; Yu L; Liu B
Exp Oncol; 2007 Jun; 29(2):137-43. PubMed ID: 17704747
[TBL] [Abstract][Full Text] [Related]
23. Signal transduction by B7/BB1 expressed on activated T lymphocytes: cross-linking of B7/BB1 induces protein tyrosine phosphorylation and synergizes with signalling through T-cell receptor/CD3.
Hirokawa M; Kitabayashi A; Kuroki J; Miura AB
Immunology; 1995 Oct; 86(2):155-61. PubMed ID: 7490112
[TBL] [Abstract][Full Text] [Related]
24. CD40-CD40 ligand interactions stimulate B cell antigen processing.
Faassen AE; Dalke DP; Berton MT; Warren WD; Pierce SK
Eur J Immunol; 1995 Dec; 25(12):3249-55. PubMed ID: 8566008
[TBL] [Abstract][Full Text] [Related]
25. Activated B cells express CD28/B7-independent costimulatory activity.
Ding L; Shevach EM
J Immunol; 1996 Aug; 157(4):1389-96. PubMed ID: 8759718
[TBL] [Abstract][Full Text] [Related]
26. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
[TBL] [Abstract][Full Text] [Related]
27. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
[TBL] [Abstract][Full Text] [Related]
28. B-cell activation in patients with irritable bowel syndrome (IBS).
Ohman L; Lindmark AC; Isaksson S; Posserud I; Strid H; Sjövall H; Simrén M
Neurogastroenterol Motil; 2009 Jun; 21(6):644-50, e27. PubMed ID: 19222763
[TBL] [Abstract][Full Text] [Related]
29. B7-1 induces immunosuppression when expressed in cultured neonatal mice keratinocytes.
Nengwen K; Li F; Li X; Juan S; Jianjun L; Chuntao Z; Youping L
Immunobiology; 2009; 214(8):653-63. PubMed ID: 19249124
[TBL] [Abstract][Full Text] [Related]
30. Expression of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) on human hepatocellular carcinoma.
Tatsumi T; Takehara T; Katayama K; Mochizuki K; Yamamoto M; Kanto T; Sasaki Y; Kasahara A; Hayashi N
Hepatology; 1997 May; 25(5):1108-14. PubMed ID: 9141426
[TBL] [Abstract][Full Text] [Related]
31. Expression of costimulatory molecules CD80 and/or CD86 by a Kaposi's sarcoma tumor cell line induces differential T-cell activation and proliferation.
Foreman KE; Wrone-Smith T; Krueger AE; Nickoloff BJ
Clin Immunol; 1999 Jun; 91(3):345-53. PubMed ID: 10370381
[TBL] [Abstract][Full Text] [Related]
32. Functional consequences of dysregulated B7-1 (CD80) and B7-2 (CD86) expression in B or T lymphocytes of transgenic mice.
Van Parijs L; Sethna MP; Schweitzer AN; Borriello F; Sharpe AH; Abbas AK
J Immunol; 1997 Dec; 159(11):5336-44. PubMed ID: 9548473
[TBL] [Abstract][Full Text] [Related]
33. Reciprocal expression of co-stimulatory molecules, B7-1 and B7-2, on murine T cells following activation.
Prabhu Das MR; Zamvil SS; Borriello F; Weiner HL; Sharpe AH; Kuchroo VK
Eur J Immunol; 1995 Jan; 25(1):207-11. PubMed ID: 7531145
[TBL] [Abstract][Full Text] [Related]
34. Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells.
Galea-Lauri J; Darling D; Gan SU; Krivochtchapov L; Kuiper M; Gäken J; Souberbielle B; Farzaneh F
J Immunol; 1999 Jul; 163(1):62-70. PubMed ID: 10384100
[TBL] [Abstract][Full Text] [Related]
35. B7+CTLA4+ T cells engage in T-T cell interactions that mediate apoptosis: a model for lentivirus-induced T cell depletion.
Vahlenkamp TW; Bull ME; Dow JL; Collisson EW; Winslow BJ; Phadke AP; Tompkins WA; Tompkins MB
Vet Immunol Immunopathol; 2004 Apr; 98(3-4):203-14. PubMed ID: 15010229
[TBL] [Abstract][Full Text] [Related]
36. Time courses of B7 family molecules expressed on activated T-cells and their biological significance.
Sun ZW; Qiu YH; Shi YJ; Tao R; Chen J; Ge Y; Hu YM; Ma HB; Shi Q; Zhang XG
Cell Immunol; 2005; 236(1-2):146-53. PubMed ID: 16165113
[TBL] [Abstract][Full Text] [Related]
37. Expression and function of B7-1 (CD80) and B7-2 (CD86) on human epidermal Langerhans cells.
Rattis FM; Péguet-Navarro J; Staquet MJ; Dezutter-Dambuyant C; Courtellemont P; Redziniak G; Schmitt D
Eur J Immunol; 1996 Feb; 26(2):449-53. PubMed ID: 8617317
[TBL] [Abstract][Full Text] [Related]
38. The immunogenic potential of human fetal retinal pigment epithelium and its relation to transplantation.
Rezai KA; Semnani RT; Patel SC; Ernest JT; van Seventer GA
Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2662-71. PubMed ID: 9375586
[TBL] [Abstract][Full Text] [Related]
39. The infection of human dendritic cells with recombinant avipox vectors expressing a costimulatory molecule transgene (CD80) to enhance the activation of antigen-specific cytolytic T cells.
Tsang KY; Zhu M; Even J; Gulley J; Arlen P; Schlom J
Cancer Res; 2001 Oct; 61(20):7568-76. PubMed ID: 11606396
[TBL] [Abstract][Full Text] [Related]
40. Differential expression of dendritic cell markers by all-trans retinoic acid on human acute promyelocytic leukemic cell line.
Park HY; Park JY; Kim JW; Lee MJ; Jang MJ; Lee SY; Baek DW; Park YM; Lee SW; Yoon S; Bae YS; Kwak JY
Int Immunopharmacol; 2004 Dec; 4(13):1587-601. PubMed ID: 15454112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
